TABLE 2

Summary of Behavioral, Sleepiness, and Quality of Life Measures at Baseline and at 7-Month Follow-up After Adenotonsillectomy

Neurobehavioral MeasureNo. With Available Data (Baseline/Follow-up)BaselineFollow-upChange From BaselineaPbEffect Size
NEPSY-A/E score(184/183)102.3 ± 15.7109.2 ± 15.47.1 ± 13.7, n = 183<.001–0.44
BRIEF score(185/184)49.5 ± 10.846.2 ± 11.3−3.3 ± 8.3, n = 184<.0010.30
Conners’ Rating Scale(185/182)52.1 ± 11.449.2 ± 10.8−2.9 ± 9.9, n = 182<.0010.26
CBCL score(180/181)52.1 ± 10.948.2 ± 12.0−3.9 ± 8.0, n = 178<.0010.34
PedsQL (Child)(184/184)68.8 ± 15.472.3 ± 15.23.6 ± 17.2, n = 183.006−0.23
PedsQL (Parent)(185/184)78.8 ± 15.484.5 ± 14.95.7 ± 14.6, n = 184<.001−0.37
OSAS-18 score(184/183)52.8 ± 17.730.7 ± 13.8−21.9 ± 15.9, n = 182<.0011.39
ESS(185/185)7.1 ± 4.75.0 ± 4.4−2.0 ± 4.3, n = 185<.0010.44
  • Data are summarized as mean ± SD.

  • a Number of participants with available change data (baseline minus follow-up) differs slightly from the number with available data at follow-up: CBCL (n = 178), PedsQL Child (n = 183), OSAS-18 (n = 182).

  • b P values were based on paired t test of baseline and follow-up.